$243.00
-4.16-1.68%
At close: -
$243.00
0.000.00%
After Hours: Mar 28, 4:00 PM EDT
Comments
Loading...
Bio-Rad Laboratories Earnings Estimates, EPS & Revenue | NYSE:BIO | Benzinga
Bio-Rad Laboratories reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$2.640
Quarterly Revenue Estimate
$631.66M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.57B
Analyze the earnings history of Bio-Rad Laboratories using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIO | Bio-Rad Laboratories | $2.29 | $2.64 | — | — | $610.82M | $631.66M | — | — | 05/06/2025 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.10 | $2.88 | $2.90 | 0.69% | $681.18M | $679.75M | $667.50M | -1.80% | 02/13/2025 | Get Alert |
| BIO | Bio-Rad Laboratories | $2.33 | $1.16 | $2.01 | 73.28% | $632.12M | $628.17M | $649.73M | 3.43% | 10/30/2024 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.00 | $2.01 | $3.11 | 54.73% | $681.10M | $645.79M | $638.48M | -1.13% | 08/01/2024 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.34 | $2.15 | $2.29 | 6.51% | $676.84M | $619.09M | $610.82M | -1.34% | 05/07/2024 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.31 | $2.82 | $3.10 | 9.93% | $730.29M | $685.09M | $681.18M | -0.57% | 02/15/2024 | Get Alert |
| BIO | Bio-Rad Laboratories | $2.64 | $2.78 | $2.33 | -16.19% | $680.80M | $689.57M | $632.12M | -8.33% | 10/26/2023 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.38 | $2.55 | $3.00 | 17.65% | $691.10M | $687.88M | $681.10M | -0.99% | 08/03/2023 | Get Alert |
| BIO | Bio-Rad Laboratories | $4.94 | $3.54 | $3.34 | -5.65% | $700.06M | $689.83M | $676.84M | -1.88% | 05/04/2023 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.21 | $3.45 | $3.31 | -4.06% | $732.77M | $742.25M | $730.29M | -1.61% | 02/16/2023 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.71 | $2.78 | $2.60 | -6.47% | $715.20M | $679.94M | $680.80M | 0.13% | 10/27/2022 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.54 | $2.80 | $3.38 | 20.71% | $715.93M | $682.62M | $691.10M | 1.24% | 07/28/2022 | Get Alert |
| BIO | Bio-Rad Laboratories | $5.21 | $3.40 | $4.94 | 45.29% | $726.80M | $675.10M | $700.06M | 3.70% | 04/28/2022 | Get Alert |
| BIO | Bio-Rad Laboratories | $4.01 | $2.85 | $3.21 | 12.63% | $789.84M | $731.98M | $732.77M | 0.11% | 02/10/2022 | Get Alert |
| BIO | Bio-Rad Laboratories | $3.00 | $2.44 | $3.71 | 52.05% | $647.26M | $661.87M | $715.20M | 8.06% | 10/28/2021 | Get Alert |
| BIO | Bio-Rad Laboratories | $1.61 | $2.66 | $3.54 | 33.08% | $536.88M | $631.78M | $715.93M | 13.32% | 07/29/2021 | Get Alert |
| BIO | Bio-Rad Laboratories | $1.91 | $3.00 | $5.21 | 73.67% | $571.64M | $660.98M | $726.80M | 9.96% | 04/29/2021 | Get Alert |
| BIO | Bio-Rad Laboratories | $2.32 | $3.29 | $4.01 | 21.88% | $624.43M | $686.80M | $789.84M | 15.00% | 02/11/2021 | Get Alert |
| BIO | Bio-Rad Laboratories | $1.61 | $1.80 | $3.00 | 66.67% | $560.63M | $570.58M | $647.26M | 13.44% | 10/29/2020 | Get Alert |
| BIO | Bio-Rad Laboratories | $1.57 | $1.15 | $1.61 | 40.00% | $572.62M | $503.82M | $536.88M | 6.56% | 07/30/2020 | Get Alert |
| BIO | Bio-Rad Laboratories | $1.65 | $1.61 | $1.91 | 18.63% | $553.98M | $554.89M | $571.64M | 3.02% | 05/06/2020 | Get Alert |
Bio-Rad Laboratories (BIO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-13 | $2.90 | $2.88 | 0.69 % |
| Q3 | 2024-10-30 | $2.01 | $1.16 | 73.3 % |
| Q2 | 2024-08-01 | $3.11 | $2.01 | 54.7 % |
| Q1 | 2024-05-07 | $2.29 | $2.15 | 6.51 % |
Bio-Rad Laboratories (BIO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-13 | $667.50M | $679.75M | -1.80 % |
| Q3 | 2024-10-30 | $649.73M | $628.17M | 3.43 % |
| Q2 | 2024-08-01 | $638.48M | $645.79M | -1.13 % |
| Q1 | 2024-05-07 | $610.82M | $619.09M | -1.34 % |
FAQ
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories (BIO) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 13, 2025 for Q4.
What were the latest earnings per share (EPS) for Bio-Rad Laboratories (NYSE:BIO)?
The Actual EPS was $2.90, which beat the estimate of $2.88.
What were Bio-Rad Laboratories’s (NYSE:BIO) revenues?
The Actual Revenue was $667.5M, which missed the estimate of $679.8M.
Browse earnings estimates, EPS, and revenue on all stocks.